As an alternative approach, a nanoparticle-based delivery system developed by Lee and colleagues also enables in vitro delivery of cyclic dinucleotides to target STING pathways for anti-tumour effects [221] (Figure 6). The gene discussed is STING1; the disease is neoplasm.